A closely anticipated trial has concluded with disappointing results for Novo Nordisk's blockbuster drug semaglutide, the ...

Speaking to Baylor University, study co-author Dr Benjamin Deneen said that increasing levels of the protein, which ...

Jay Leno has revealed a heartbreaking struggle his wife endured due to her dementia, saying the disease caused her to start every morning for roughly three years thinking she’d just learned that her ...

An oral version of the GLP-1 drug semaglutide failed to significantly slow the disease's progression compared to a placebo.

Scientists have failed to show that weight-loss wonder drug semaglutide slows the progress of Alzheimer's disease (AD), as ...

We break down the current state of frontotemporal dementia, from bvFTD to PPA, and why 'promising' therapies are still far ...

It’s estimated that nearly 70 percent of older adults with Alzheimer’s disease or other dementias live in the community ...

The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a ...

The biomarker improvements in the EVOKE studies are worth noting, observed Howard Fillit, MD, of the Alzheimer's Drug ...

There’s rarely good news about Alzheimer’s disease, but a failed study may open the door to more research about vascular ...

As a constituent in Georgia 14th Congressional District, I would like to bring awareness to the recently introduced H.R. 6130 The Alzheimer’s Screening and Prevention (ASAP) Act . This legislation ...

Despite encouraging biomarker shifts, oral semaglutide failed to slow cognitive decline in early Alzheimer’s, leading to an early end of the trial extension.